Patent Litigation Settlements Should Be Filed With FDA, FTC Says

FDA's 180-day ANDA exclusivity rule should require patent litigation settlements between branded companies and ANDA applicants to be filed with FDA, the Federal Trade Commission suggested in comments on FDA's proposed rule.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet